动物寄生虫杀虫剂市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024 年全球动物寄生虫杀虫剂市场价值为 129 亿美元，预计 2025 年至 2034 年的复合年增长率为 5.3%。这一增长受到全球动物数量的增加、宠物拥有量的增加、寄生虫感染的流行以及动物保健支出的增加的推动。肠道寄生虫和蜱传疾病等传染病继续构成健康风险，导致对预防和治疗的需求增加。动物寄生虫杀虫剂，包括外用溶液、口服药物和注射剂，在控制寄生虫感染和保障动物健康方面发挥至关重要的作用。宠物主人将预防寄生虫放在首位，这导致狗和猫等伴侣动物对这些产品的需求激增。畜牧业也依赖抗寄生虫药物来维持动物健康和维持粮食生产。远距医疗平台和即时诊断等兽医学技术的进步也促进了市场扩张。

动物寄生虫杀灭剂依其功能分类，主要包括外寄生虫杀灭剂、内寄生虫杀灭剂和内寄生虫杀灭剂。外寄生虫杀虫剂领域包括浇注剂、口服药片、点滴剂、喷雾剂、浸剂、耳标和项圈，2024 年的收入最高，达到 70 亿美元。跳蚤、蜱虫和螨虫等外部寄生虫的广泛存在持续推动着对这些治疗的需求，特别是在气候变迁的地区。畜牧农民和宠物主人依靠这些杀寄生虫剂来有效控制寄生虫。点滴治疗和喷雾等配方创新提高了依从性和功效，进一步刺激了市场需求。政府为确保更好的动物健康和卫生而采取的措施也有助于外寄生虫杀虫剂保持强大的市场地位。

动物寄生虫杀虫剂市场按类型进一步细分为非处方药 (OTC) 和处方药。 2024 年，处方药市场占据主导地位，市占率达 74.1%。处方类杀虫剂需要兽医监督，以确保为动物製定量身定制的治疗方案。这些产品通常更加精緻，专门用于治疗目标寄生虫感染，与非处方药替代品相比更有效。它们的效力和特异性使它们成为兽医和宠物主人的首选。

根据动物类型对市场进行细分，将杀寄生虫剂分为伴侣动物和农场动物。 2024 年，伴侣动物细分市场的收入份额最高，为 56.9%。宠物收养数量的增加和人们对寄生虫疾病预防意识的增强推动了对这些治疗的需求。跳蚤、蜱虫、螨虫和蠕虫等寄生虫经常影响宠物，导致各种健康问题。製造商不断开发创新解决方案来满足日益增长的需求。

市场进一步依药物类别分类，包括化学合成、拟除虫菊酯、大环内酯、有机磷酸酯、苯并咪唑等。化学合成领域在 2024 年规模最大，预计在预测期内的复合年增长率为 5%。这些杀寄生虫剂因其广谱活性、有效性和价格实惠而被广泛使用。它们在宠物护理和牲畜管理中发挥着至关重要的作用，支持动物健康和生产力。

依照最终用途，市场分为动物农场、兽医医院和诊所以及家庭护理机构。 2024 年，兽医院和诊所占据了最大的市场份额，预计到 2034 年将达到 127 亿美元。这些机构僱用训练有素的专业人员，确保对寄生虫感染进行准确的诊断和治疗。他们在提供处方治疗、先进诊断和专业护理方面发挥的作用巩固了其在市场上的主导地位。宠物保险的普及率不断提高以及兽医护理支出的增加也促进了这一领域的持续扩张。

从地理位置来看，北美在 2024 年占据动物寄生虫杀虫剂市场的主导地位，占有 37.2% 的份额，预计在预测期内将以 4% 的复合年增长率增长。伴侣动物和牲畜数量的增加，以及政府对动物健康计画的大力支持，推动了该地区对抗寄生虫产品的需求。光是美国市场在 2021 年的价值就为 38 亿美元，2022 年成长至 39 亿美元，2023 年达到 42 亿美元。随着兽药的不断进步和对动物保健的投资不断增加，市场将保持上升趋势。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
• 产业衝击力
  • 成长动力
    • 动物保健支出增加
    • 养宠物的趋势日益增长
    • 人类食品中对动物性蛋白质的需求迅速增加
    • 人畜共通传染病和跨界疾病发生率不断上升
    • 动物疾病发生率不断上升
  • 产业陷阱与挑战
    • 食用动物杀寄生虫剂消费限制
    • 宠物照护费用高
• 成长潜力分析
• 监管格局
• 2024 年各产品定价分析
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 策略仪表板

第五章：市场估计与预测：按产品，2021 年至 2034 年

• 主要趋势
• 杀外寄生虫剂
  • 浇注式和点涂式
  • 口服锭剂
  • 喷雾剂
  • 沾酱
  • 耳标
  • 项圈
  • 其他杀外寄生虫剂
• 体内寄生虫杀灭剂
  • 口服液
  • 口服固体药物
  • 注射剂
  • 饲料添加剂
  • 其他体内寄生虫杀灭剂
• 内虫杀灭剂

第六章：市场估计与预测：按类型，2021 年至 2034 年

• 主要趋势
• 场外交易（OTC）
• 处方

第七章：市场估计与预测：依动物类型，2021 年至 2034 年

• 主要趋势
• 伴侣动物
  • 狗
  • 猫
  • 马匹
  • 其他伴侣动物
• 农场动物
  • 家禽
  • 猪
  • 牛
  • 绵羊和山羊
  • 其他农场动物

第 8 章：市场估计与预测：按药物类别，2021 年至 2034 年

• 主要趋势
• 化学合成
• 大环内酯
• 拟除虫菊酯
• 有机磷酸酯
• 苯并咪唑类
• 其他药物类别

第九章：市场估计与预测：依最终用途，2021 年至 2034 年

• 主要趋势
• 兽医医院和诊所
• 动物农场
• 居家照护环境

第十章：市场估计与预测：按地区，2021 年至 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 俄罗斯
  • 波兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 土耳其

第 11 章：公司简介

• Boehringer Ingelheim International
• Bimeda
• Biogenesis Bagó
• Ceva Sante Animal
• Dechra Pharmaceuticals
• Elanco Animal Health
• Merck
• Norbrook Laboratories
• Neogen Corporation
• Ourofino Saude Animal
• Phibro Animal Health
• PetIQ
• Virbac
• Vetoquinol
• Zoetis

The Global Animal Parasiticides Market was valued at USD 12.9 billion in 2024 and is projected to grow at a CAGR of 5.3% from 2025 to 2034. This growth is fueled by the rising global animal population, increasing pet ownership, the prevalence of parasitic infections, and higher spending on animal healthcare. Contagious diseases such as intestinal parasites and tick-borne illnesses continue to pose health risks, prompting increased demand for preventive and curative treatments. Animal parasiticides, including topical solutions, oral medications, and injectables, play a crucial role in controlling infestations and safeguarding animal health. Pet owners are prioritizing parasite prevention, which has led to a surge in demand for these products in companion animals like dogs and cats. The livestock industry also relies on antiparasitic drugs to maintain animal health and sustain food production. Technological advancements in veterinary medicine, such as telemedicine platforms and point-of-care diagnostics, are also contributing to market expansion.

Animal parasiticides are categorized based on their function, with key segments including ectoparasiticides, endoparasiticides, and endectocides. The ectoparasiticides segment, which includes pour-ons, oral tablets, spot-ons, sprays, dips, ear tags, and collars, generated the highest revenue in 2024, amounting to USD 7 billion. The widespread presence of external parasites like fleas, ticks, and mites continues to drive demand for these treatments, particularly in regions with varied climates. Livestock farmers and pet owners rely on these parasiticides for effective parasite control. Innovations in formulations, including spot-on treatments and sprays, have improved adherence and efficacy, further boosting market demand. Government initiatives aimed at ensuring better animal health and hygiene also contribute to the strong market position of ectoparasiticides.

The animal parasiticides market is further segmented by type into over-the-counter (OTC) and prescription products. In 2024, the prescription segment dominated with a 74.1% market share. Prescription-based parasiticides require veterinary oversight, ensuring tailored treatment plans for animals. These products are typically more refined and specifically designed to treat targeted parasite infestations, making them more effective compared to OTC alternatives. Their potency and specificity have made them the preferred choice among veterinarians and pet owners.

Market segmentation by animal type classifies parasiticides into companion animals and farm animals. In 2024, the companion animals segment held the highest revenue share at 56.9%. The increasing number of pet adoptions and the growing awareness of parasitic disease prevention have fueled demand for these treatments. Parasites such as fleas, ticks, mites, and worms frequently affect pets, leading to various health concerns. Manufacturers continue to develop innovative solutions to meet this rising demand.

The market is further categorized by drug class, including chemical synthetic, pyrethroids, macrocyclic lactones, organophosphates, benzimidazoles, and others. The chemical synthetic segment was the largest in 2024 and is expected to grow at a CAGR of 5% over the forecast period. These parasiticides are widely used due to their broad-spectrum activity, effectiveness, and affordability. They play a vital role in both pet care and livestock management, supporting animal health and productivity.

In terms of end use, the market is divided into animal farms, veterinary hospitals and clinics, and home care settings. Veterinary hospitals and clinics accounted for the largest market share in 2024 and are projected to reach USD 12.7 billion by 2034. These facilities employ trained professionals who ensure accurate diagnosis and treatment of parasitic infections. Their role in providing prescription-based treatments, advanced diagnostics, and specialized care has solidified their dominance in the market. The growing adoption of pet insurance and higher expenditure on veterinary care also contribute to this segment's continued expansion.

Geographically, North America led the animal parasiticides market in 2024, holding a 37.2% share, and is expected to grow at a 4% CAGR over the forecast period. The increasing number of companion and livestock animals, along with strong government support for animal health initiatives, has driven demand for antiparasitic products in the region. The U.S. market alone was valued at USD 3.8 billion in 2021, grew to USD 3.9 billion in 2022, and reached USD 4.2 billion in 2023. With continuous advancements in veterinary pharmaceuticals and increasing investments in animal healthcare, the market is set to maintain its upward trajectory.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing in animal healthcare expenditure
    • 3.2.1.2 Growing trend of adoption of pet animals
    • 3.2.1.3 Rapidly increasing demand for animal protein in human food
    • 3.2.1.4 Increasing incidences of zoonotic and transboundary diseases
    • 3.2.1.5 Increasing prevalence of animal diseases
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Restrictions on parasiticide consumption in food animals
    • 3.2.2.2 High pet care cost
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Pricing analysis, by product, 2024
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Ectoparasiticides
  • 5.2.1 Pour-ons and spot-ons
  • 5.2.2 Oral tablets
  • 5.2.3 Sprays
  • 5.2.4 Dips
  • 5.2.5 Ear tags
  • 5.2.6 Collars
  • 5.2.7 Other ectoparasiticides
• 5.3 Endoparasiticides
  • 5.3.1 Oral liquids
  • 5.3.2 Oral solids
  • 5.3.3 Injectables
  • 5.3.4 Feed additives
  • 5.3.5 Other endoparasiticides
• 5.4 Endectocides

Chapter 6 Market Estimates and Forecast, By Type, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Over the counter (OTC)
• 6.3 Prescription

Chapter 7 Market Estimates and Forecast, By Animal Type, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Companion animals
  • 7.2.1 Dogs
  • 7.2.2 Cats
  • 7.2.3 Horses
  • 7.2.4 Other companion animals
• 7.3 Farm animals
  • 7.3.1 Poultry
  • 7.3.2 Swine
  • 7.3.3 Cattle
  • 7.3.4 Sheep and goats
  • 7.3.5 Other farm animals

Chapter 8 Market Estimates and Forecast, By Drug Class, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Chemical synthetic
• 8.3 Macrocyclic lactones
• 8.4 Pyrethroids
• 8.5 Organophosphates
• 8.6 Benzimidazoles
• 8.7 Other drug classes

Chapter 9 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 9.1 Key trends
• 9.2 Veterinary hospitals and clinics
• 9.3 Animal farms
• 9.4 Home care settings

Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Russia
  • 10.3.7 Poland
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 Turkey

Chapter 11 Company Profiles

• 11.1 Boehringer Ingelheim International
• 11.2 Bimeda
• 11.3 Biogenesis Bagó
• 11.4 Ceva Sante Animal
• 11.5 Dechra Pharmaceuticals
• 11.6 Elanco Animal Health
• 11.7 Merck
• 11.8 Norbrook Laboratories
• 11.9 Neogen Corporation
• 11.10 Ourofino Saude Animal
• 11.11 Phibro Animal Health
• 11.12 PetIQ
• 11.13 Virbac
• 11.14 Vetoquinol
• 11.15 Zoetis